Merck Announces Collaboration with Mersana Therapeutics to Develop Novel Immunostimulatory Antibody-Drug Conjugates
DARMSTADT, Germany -- (BUSINESS WIRE) -- Merck, a leading science and technology company, today announced a research collaboration and commercial license agreement with Mersana Therapeutics,......